Mitogen-activated protein kinase p38 regulates krox-20 to direct schwann cell differentiation and peripheral myelination

GLIA

Volumn 60, Issue 7, 2012, Pages 1130-1144

  Hossain, Shireen ^a   de la Cruz Morcillo, Miguel Angel ^b   Sanchez Prieto, Ricardo ^b   Almazan, Guillermina ^a  

^a MCGILL UNIVERSITY   (Canada)

^b Universidad de Castilla La Mancha   (Spain)

Author keywords

CREB; MAPKAPK 2 (MK2); MSK 1; P27kip1; Sox10

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; 4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 14; MITOGEN ACTIVATED PROTEIN KINASE P38; MYELIN PROTEIN; OCTAMER TRANSCRIPTION FACTOR 6; PROTEIN; PROTEIN KROX 20; PROTEIN P27; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE 1; TRANSCRIPTION FACTOR SOX10; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; GENE SILENCING; IMMUNOCYTOCHEMISTRY; MYELINATION; NERVE CELL DIFFERENTIATION; NERVE FIBER; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHWANN CELL;

ANIMALS; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; EARLY GROWTH RESPONSE PROTEIN 2; GANGLIA, SPINAL; MYELIN SHEATH; NEURONS; OCTAMER TRANSCRIPTION FACTOR-6; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RATS; RATS, SPRAGUE-DAWLEY; RNA, SMALL INTERFERING; SCHWANN CELLS; SOXE TRANSCRIPTION FACTORS;

EID: 84860675251     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.22340     Document Type: Article

References (53)

1. Arthur-Farraj P, Wanek K, Hantke J, Davis CM, Jayakar A, Parkinson DB, Mirsky R, Jessen KR. 2011. Mouse schwann cells need both NRG1 and cyclic AMP to myelinate. Glia 59: 720-733.
2. Bellone E, Di ME, Soriani S, Varese A, Doria LL, Ajmar F, Mandich P. 1999. A novel mutation (D305V) in the early growth response 2 gene is associated with severe Charcot-Marie-Tooth type 1 disease. Hum Mutat 14: 353-354.
3. Bhat NR, Zhang P, Mohanty SB. 2007. p38 MAP kinase regulation of oligodendrocyte differentiation with CREB as a potential target. Neurochem Res 32: 293-302.
4. Bondurand N, Girard M, Pingault V, Lemort N, Dubourg O, Goossens M. 2001. Human Connexin 32, a gap junction protein altered in the X-linked form of Charcot-Marie-Tooth disease, is directly regulated by the transcription factor SOX10. Hum Mol Genet 10: 2783-2795.
5. Boutry JM, Hauw JJ, Gansmuller A, Di-Bert N, Pouchelet M, Baron-Van EA. 1992. Establishment and characterization of a mouse Schwann cell line which produces myelin in vivo. J Neurosci Res 32: 15-26.
6. Chen CY, Shyu AB. 1995. AU-rich elements: Characterization and importance in mRNA degradation. Trends Biochem Sci 20: 465-470.
7. Chew LJ, Coley W, Cheng Y, Gallo V. 2010. Mechanisms of regulation of oligodendrocyte development by p38 mitogen-activated protein kinase. J Neurosci 30: 11011-11027.
8. Davidson W, Frego L, Peet GW, Kroe RR, Labadia ME, Lukas SM, Snow RJ, Jakes S, Grygon CA, Pargellis C, Werneburg BG. 2004. Discovery and characterization of a substrate selective p38alpha inhibitor. Biochemistry 43: 11658-11671.
9. Dean JL, Sully G, Clark AR, Saklatvala J. 2004. The involvement of AU-rich element-binding proteins in p38 mitogen-activated protein kinase pathway-mediated mRNA stabilisation. Cell Signal 16: 1113-1121.
10. Fragoso G, Haines JD, Roberston J, Pedraza L, Mushynski WE, Almazan G. 2007. p38 mitogen-activated protein kinase is required for central nervous system myelination. Glia 55: 1531-1541.
11. Fragoso G, Robertson J, Athlan E, Tam E, Almazan G, Mushynski WE. 2003. Inhibition of p38 mitogen-activated protein kinase interferes with cell shape changes and gene expression associated with Schwann cell myelination. Exp Neurol 183: 34-46.
12. Frevel MA, Bakheet T, Silva AM, Hissong JG, Khabar KS, Williams BR. 2003. p38 Mitogen-activated protein kinase-dependent and -independent signaling of mRNA stability of AU-rich element-containing transcripts. Mol Cell Biol 23: 425-436.
13. Gao X, Daugherty RL, Tourtellotte WG. 2007. Regulation of low affinity neurotrophin receptor (p75(NTR)) by early growth response (Egr) transcriptional regulators. Mol Cell Neurosci 36: 501-514.
14. Ghislain J, Charnay P. 2006. Control of myelination in Schwann cells: A Krox20 cis-regulatory element integrates Oct6, Brn2 and Sox10 activities. EMBO Rep 7: 52-58.
15. Gillespie CS, Sherman DL, Fleetwood-Walker SM, Cottrell DF, Tait S, Garry EM, Wallace VC, Ure J, Griffiths IR, Smith A, Brophy PJ. 2000. Peripheral demyelination and neuropathic pain behavior in periaxin-deficient mice. Neuron 26: 523-531.
16. Haines JD, Fang J, Mushynski WE, Almazan G. 2010. Mitogen-activated protein kinase activated protein kinase 2 (MK2) participates in p38 MAPK regulated control of oligodendrocyte differentiation. Glia 58: 1384-1393.
17. Heinen A, Kremer D, Gottle P, Kruse F, Hasse B, Lehmann H, Hartung HP, Kury P. 2008. The cyclin-dependent kinase inhibitor p57kip2 is a negative regulator of Schwann cell differentiation and in vitro myelination. Proc Natl Acad Sci USA 105: 8748-8753.
18. Hitti E, Iakovleva T, Brook M, Deppenmeier S, Gruber AD, Radzioch D, Clark AR, Blackshear PJ, Kotlyarov A, Gaestel M. 2006. Mitogen-activated protein kinase-activated protein kinase 2 regulates tumor necrosis factor mRNA stability and translation mainly by altering tristetraprolin expression, stability, and binding to adenine/uridine-rich element. Mol Cell Biol 26: 2399-2407.
19. Hossain S, Fragoso G, Mushynski WE, Almazan G. 2010. Regulation of peripheral myelination by Src-like kinases. Exp Neurol 226: 47-57.
20. Jagalur NB, Ghazvini M, Mandemakers W, Driegen S, Maas A, Jones EA, Jaegle M, Grosveld F, Svaren J, Meijer D. 2011. Functional dissection of the Oct6 Schwann cell enhancer reveals an essential role for dimeric Sox10 binding. J Neurosci 31: 8585-8594.
21. Jessen KR, Mirsky R. 2008. Negative regulation of myelination: Relevance for development, injury, and demyelinating disease. Glia 56: 1552-1565.
22. Johannessen M, Delghandi MP, Moens U. 2004. What turns CREB on? Cell Signal 16: 1211-1227.
23. Jones EA, Jang SW, Mager GM, Chang LW, Srinivasan R, Gokey NG, Ward RM, Nagarajan R, Svaren J. 2007. Interactions of Sox10 and Egr2 in myelin gene regulation. Neuron Glia Biol 3: 377-387.
24. Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA, Crabtree GR. 2009. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science 323: 651-654.
25. Landry J, Huot J. 1995. Modulation of actin dynamics during stress and physiological stimulation by a signaling pathway involving p38 MAP kinase and heat-shock protein 27. Biochem Cell Biol 73: 703-707.
26. Le N, Nagarajan R, Wang JY, Araki T, Schmidt RE, Milbrandt J. 2005. Analysis of congenital hypomyelinating Egr2Lo/Lo nerves identifies Sox2 as an inhibitor of Schwann cell differentiation and myelination. Proc Natl Acad Sci USA 102: 2596-2601.
27. LeBlanc SE, Jang SW, Ward RM, Wrabetz L, Svaren J. 2006. Direct regulation of myelin protein zero expression by the Egr2 transactivator. J Biol Chem 281: 5453-5460.
28. LeBlanc SE, Ward RM, Svaren J. 2007. Neuropathy-associated Egr2 mutants disrupt cooperative activation of myelin protein zero by Egr2 and Sox10. Mol Cell Biol 27: 3521-3529.
29. Lee MM, Badache A, DeVries GH. 1999. Phosphorylation of CREB in axon-induced Schwann cell proliferation. J Neurosci Res 55: 702-712.
30. Maitra S, Chou CF, Luber CA, Lee KY, Mann M, Chen CY. 2008. The AU-rich element mRNA decay-promoting activity of BRF1 is regulated by mitogen-activated protein kinase-activated protein kinase 2. RNA 14: 950-959.
31. Monuki ES, Weinmaster G, Kuhn R, Lemke G. 1989. SCIP: A glial POU domain gene regulated by cyclic AMP. Neuron 3: 783-793.
32. Murphy P, Topilko P, Schneider-Maunoury S, Seitanidou T, Baron-Van EA, Charnay P. 1996. The regulation of Krox-20 expression reveals important steps in the control of peripheral glial cell development. Development 122: 2847-2857.
33. Nagarajan R, Svaren J, Le N, Araki T, Watson M, Milbrandt J. 2001. EGR2 mutations in inherited neuropathies dominant-negatively inhibit myelin gene expression. Neuron 30: 355-368.
34. Ono K, Han J. 2000. The p38 signal transduction pathway: Activation and function. Cell Signal 12: 1-13.
35. Parkinson DB, Bhaskaran A, Arthur-Farraj P, Noon LA, Woodhoo A, Lloyd AC, Feltri ML, Wrabetz L, Behrens A, Mirsky R, Jessen KR. 2008. c-Jun is a negative regulator of myelination. J Cell Biol 181: 625-637.
36. Parkinson DB, Bhaskaran A, Droggiti A, Dickinson S, D'Antonio M, Mirsky R, Jessen KR. 2004. Krox-20 inhibits Jun-NH2-terminal kinase/c-Jun to control Schwann cell proliferation and death. J Cell Biol 164: 385-394.
37. Parkinson DB, Dickinson S, Bhaskaran A, Kinsella MT, Brophy PJ, Sherman DL, Sharghi-Namini S, Duran Alonso MB, Mirsky R, Jessen KR. 2003. Regulation of the myelin gene periaxin provides evidence for Krox-20-independent myelin-related signalling in Schwann cells. Mol Cell Neurosci 23: 13-27.
38. Peirano RI, Goerich DE, Riethmacher D, Wegner M. 2000. Protein zero gene expression is regulated by the glial transcription factor Sox10. Mol Cell Biol 20: 3198-3209.
39. Pimienta G, Pascual J. 2007. Canonical and alternative MAPK signaling. Cell Cycle 6: 2628-2632.
40. Raman M, Chen W, Cobb MH. 2007. Differential regulation and properties of MAPKs. Oncogene 26: 3100-3112.
41. Reiprich S, Kriesch J, Schreiner S, Wegner M. 2010. Activation of Krox20 gene expression by Sox10 in myelinating Schwann cells. J Neurochem 112: 744-754.
42. Rolli M, Kotlyarov A, Sakamoto KM, Gaestel M, Neininger A. 1999. Stress-induced stimulation of early growth response gene-1 by p38/stress-activated protein kinase 2 is mediated by a cAMP-responsive promoter element in a MAPKAP kinase 2-independent manner. J Biol Chem 274: 19559-19564.
43. Ronkina N, Kotlyarov A, Gaestel M. 2008. MK2 and MK3-A pair of isoenzymes? Front Biosci 13: 5511-5521.
44. Roux PP, Blenis J. 2004. ERK and p38 MAPK-activated protein kinases: A family of protein kinases with diverse biological functions. Microbiol Mol Biol Rev 68: 320-344.
45. Stokoe D, Engel K, Campbell DG, Cohen P, Gaestel M. 1992. Identification of MAPKAP kinase 2 as a major enzyme responsible for the phosphorylation of the small mammalian heat shock proteins. FEBS Lett 313: 307-313.
46. Svaren J, Meijer D. 2008. The molecular machinery of myelin gene transcription in Schwann cells. Glia 56: 1541-1551.
47. Timmerman V, De JP, Ceuterick C, De VE, Lofgren A, Nelis E, Warner LE, Lupski JR, Martin JJ, Van BC. 1999. Novel missense mutation in the early growth response 2 gene associated with Dejerine-Sottas syndrome phenotype. Neurology 52: 1827-1832.
48. Topilko P, Levi G, Merlo G, Mantero S, Desmarquet C, Mancardi G, Charnay P. 1997. Differential regulation of the zinc finger genes Krox-20 and Krox-24 (Egr-1) suggests antagonistic roles in Schwann cells. J Neurosci Res 50: 702-712.
49. Topilko P, Schneider-Maunoury S, Levi G, Baron-Van EA, Chennoufi AB, Seitanidou T, Babinet C, Charnay P. 1994. Krox-20 controls myelination in the peripheral nervous system. Nature 371: 796-799.
50. Wei Q, Miskimins WK, Miskimins R. 2004. Sox10 acts as a tissue-specific transcription factor enhancing activation of the myelin basic protein gene promoter by p27Kip1 and Sp1. J Neurosci Res 78: 796-802.
51. Wiggin GR, Soloaga A, Foster JM, Murray-Tait V, Cohen P, Arthur JS. 2002. MSK1 and MSK2 are required for the mitogen- and stress-induced phosphorylation of CREB and ATF1 in fibroblasts. Mol Cell Biol 22: 2871-2881.
52. Wood P, Moya F, Eldridge C, Owens G, Ranscht B, Schachner M, Bunge M, Bunge R. 1990. Studies of the initiation of myelination by Schwann cells. Ann N Y Acad Sci 605: 1-14.
53. Zorick TS, Syroid DE, Arroyo E, Scherer SS, Lemke G. 1996. The transcription factors SCIP and Krox-20 mark distinct stages and cell fates in Schwann cell differentiation. Mol Cell Neurosci 8: 129-145.